B Doiron1, W Hu, L Norton, R A DeFronzo. 1. Diabetes Division, University of Texas Health Science Center at San Antonio, Mail Code 7886, 7703 Floyd Curl Drive, San Antonio, TX 78299, USA. doiron@uthscsa.edu
Abstract
AIMS/HYPOTHESIS: The physiological significance of growth factor receptor-bound protein-10 (GRB10) in the pancreas is unclear. We hypothesised that GRB10 is involved in pancreatic apoptosis, as GRB10 binds with a family of cell-survival-related proteins implicated in apoptosis. METHODS: Lentiviral vector small hairpin RNA (shRNA) targeting Grb10 was injected in vivo via an intraductal pancreatic route to target pancreatic tissues in adult mice, which were studied 2 weeks post-injection. RESULTS: Using the TUNEL assay, we demonstrated for the first time that in vivo injection of lentivirus shRNA Grb10 directly into the adult mouse pancreas induced apoptosis in both exocrine and endocrine (alpha and beta) cells. This effect was more pronounced in alpha cells. Levels of the pro-apoptotic protein BCL2-interacting mediator of cell death (BIM) in islets was higher in lentivirus shRNA Grb10 than in lentivirus shRNA scramble mice. In the apoptotic pathway, BIM initiates apoptosis signalling, leading to activation of the caspase cascade. We propose that, when complexed with GRB10, BIM is inactive. On activation by stress signalling or, in the present study, following injection of lentivirus shRNA Grb10 into pancreas, BIM becomes unbound from GRB10 and activates the caspase cascade. Indeed, caspase-3 activity in islets was higher in the experimental than in the control group. Apoptosis induced by shRNA Grb10 resulted in a 34% decrease in fasting plasma glucagon. Mice injected with shRNA Grb10 had improved glucose tolerance despite reduced insulin secretion compared with shRNA scramble control mice. CONCLUSIONS/ INTERPRETATION: GRB10 is critically involved in alpha cell survival and, as a result, plays an important role in regulating basal glucagon secretion and glucose tolerance in adult mice.
AIMS/HYPOTHESIS: The physiological significance of growth factor receptor-bound protein-10 (GRB10) in the pancreas is unclear. We hypothesised that GRB10 is involved in pancreatic apoptosis, as GRB10 binds with a family of cell-survival-related proteins implicated in apoptosis. METHODS: Lentiviral vector small hairpin RNA (shRNA) targeting Grb10 was injected in vivo via an intraductal pancreatic route to target pancreatic tissues in adult mice, which were studied 2 weeks post-injection. RESULTS: Using the TUNEL assay, we demonstrated for the first time that in vivo injection of lentivirus shRNA Grb10 directly into the adult mouse pancreas induced apoptosis in both exocrine and endocrine (alpha and beta) cells. This effect was more pronounced in alpha cells. Levels of the pro-apoptotic protein BCL2-interacting mediator of cell death (BIM) in islets was higher in lentivirus shRNA Grb10 than in lentivirus shRNA scramble mice. In the apoptotic pathway, BIM initiates apoptosis signalling, leading to activation of the caspase cascade. We propose that, when complexed with GRB10, BIM is inactive. On activation by stress signalling or, in the present study, following injection of lentivirus shRNA Grb10 into pancreas, BIM becomes unbound from GRB10 and activates the caspase cascade. Indeed, caspase-3 activity in islets was higher in the experimental than in the control group. Apoptosis induced by shRNA Grb10 resulted in a 34% decrease in fasting plasma glucagon. Mice injected with shRNA Grb10 had improved glucose tolerance despite reduced insulin secretion compared with shRNA scramble control mice. CONCLUSIONS/ INTERPRETATION:GRB10 is critically involved in alpha cell survival and, as a result, plays an important role in regulating basal glucagon secretion and glucose tolerance in adult mice.
Authors: J C Brüning; M D Michael; J N Winnay; T Hayashi; D Hörsch; D Accili; L J Goodyear; C R Kahn Journal: Mol Cell Date: 1998-11 Impact factor: 17.970
Authors: Shuping Zhang; Alejandra Macias-Garcia; Jacob C Ulirsch; Jason Velazquez; Vincent L Butty; Stuart S Levine; Vijay G Sankaran; Jane-Jane Chen Journal: Elife Date: 2019-04-29 Impact factor: 8.140
Authors: Kayla A Quirin; Jason J Kwon; Arafat Alioufi; Tricia Factora; Constance J Temm; Max Jacobsen; George E Sandusky; Kim Shontz; Louis G Chicoine; K Reed Clark; Joshua T Mendell; Murray Korc; Janaiah Kota Journal: Mol Ther Methods Clin Dev Date: 2017-09-30 Impact factor: 6.698
Authors: Inga Prokopenko; Wenny Poon; Reedik Mägi; Rashmi Prasad B; S Albert Salehi; Peter Almgren; Peter Osmark; Nabila Bouatia-Naji; Nils Wierup; Tove Fall; Alena Stančáková; Adam Barker; Vasiliki Lagou; Clive Osmond; Weijia Xie; Jari Lahti; Anne U Jackson; Yu-Ching Cheng; Jie Liu; Jeffrey R O'Connell; Paul A Blomstedt; Joao Fadista; Sami Alkayyali; Tasnim Dayeh; Emma Ahlqvist; Jalal Taneera; Cecile Lecoeur; Ashish Kumar; Ola Hansson; Karin Hansson; Benjamin F Voight; Hyun Min Kang; Claire Levy-Marchal; Vincent Vatin; Aarno Palotie; Ann-Christine Syvänen; Andrea Mari; Michael N Weedon; Ruth J F Loos; Ken K Ong; Peter Nilsson; Bo Isomaa; Tiinamaija Tuomi; Nicholas J Wareham; Michael Stumvoll; Elisabeth Widen; Timo A Lakka; Claudia Langenberg; Anke Tönjes; Rainer Rauramaa; Johanna Kuusisto; Timothy M Frayling; Philippe Froguel; Mark Walker; Johan G Eriksson; Charlotte Ling; Peter Kovacs; Erik Ingelsson; Mark I McCarthy; Alan R Shuldiner; Kristi D Silver; Markku Laakso; Leif Groop; Valeriya Lyssenko Journal: PLoS Genet Date: 2014-04-03 Impact factor: 5.917